Table 3.
Tobacco and waterpipe smoking, alcohol consumption, and drug abuse
| Risk factor | Study | Country of study | Study period | Study setting | Case number | Control number | OR | AOR # | 95% CI | P |
|---|---|---|---|---|---|---|---|---|---|---|
| Cigarette smoking | Halawani et al. 23 | Saudi Arabia | 2017-2018 | Hospital-based## (single center) |
80 | 160 | - | 4.16 | 1.44-11.97 | < 0.050 |
| Abbasi et al. 30 | Iran | 2013-2014 | Population-based | 660 | 421 | - | 0.62 | 0.36-1.05 | 0.075 | |
| Eftekharian et al. 27 * | Iran | 2013 | Population-based | 250 | 250 | 2.86 | - | 1.30-6.33 | - | |
| Eftekharian et al. 27 ** | Iran | 2013 | Population-based | 250 | 250 | 2.08 | - | 0.81-5.31 | - | |
| Mansouri et al. 22 | Iran | 2008-2013 | Population-based | 1217 | 787 | _ | 1.93 | 1.31-2.73 | < 0.001 | |
| Al-Afasy et al. 37 | Kuwait | 2010-2012 | Population-based | 101 | 202 | 1.70 | _ | 0.90-3.40 | 0.097 | |
| Alonso et al. 32 | Iran | 2007-2010 | Population-based | 394 | 394 | - | 1.72 | 0.90-3.30 | - | |
| Al-Shammri et al. 25 | Kuwait | - | Hospital-based### (single center) |
195 | 146 | - | 1.90 | 0.80-4.50 | 0.128 | |
| Roudbari et al. 33 *** | Iran | - | Population-based | 144 | 256 | 2.43 | - | 1.28-4.60 | 0.007 | |
| Female cigarette smoking | Alonso et al. 32 | Iran | 2007-2010 | Population-based | 394 | 394 | - | 6.48 | 1.46-28.78 | 0.002 |
| Tobacco | Abdollahpour et al. 31 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.69 | 1.24-2.31 | < 0.001 |
| Passive smoking¥ | Halawani et al. 23 | Saudi Arabia | 2017-2018 | Hospital-based## (single center) |
80 | 160 | 1.28 | - | 0.75-2.20 | - |
| Abdollahpour et al. 35 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.48 | 1.14-1.93 | 0.004 | |
| Abdollahpour et al. 31 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.85 | 1.48-2.32 | < 0.001 | |
| Abbasi et al. 30 | Iran | 2013-2014 | Population-based | 660 | 421 | - | 1.13 | 0.71-1.78 | 0.614 | |
| Passive smoking during childhood | Eftekharian et al. 27 | Iran | 2013 | Population-based | 250 | 250 | 2.25 | - | 1.57-3.20 | - |
| Al Wutayd et al. 24 | Saudi Arabia | - | Hospital-based## (multi center) |
307 | 307 | 1.00 | - | 0.72-1.39 | > 0.999 | |
| Ex-smoker* | Al Wutayd et al. 24 | Saudi Arabia | - | Hospital-based## (multi center) |
307 | 307 | 1.32 | - | 0.84-1.56 | 0.430 |
| Current smoker | Al Wutayd et al. 24 | Saudi Arabia | - | Hospital-based## (multi center) |
307 | 307 | 1.16 | - | 0.77-1.76 | 0.470 |
| Waterpipe smoking | Abdollahpour et al. 35 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.69 | 1.22-2.34 | 0.001 |
| Abdollahpour et al.31 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.77 | 1.36-2.31 | < 0.001 | |
| Alcohol | Abdollahpour et al. 35 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.61 | 1.11-2.33 | < 0.012 |
| Drug abuse | ||||||||||
| Life time drug abuse | Abdollahpour et al. 35 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 2.93 | 1.83-4.70 | < 0.001 |
| Drug abuse (opioids) | Abdollahpour et al. 35 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.00 | 0.52-1.92 | 0.998 |
| Drug abuse (cannabis) | Abdollahpour et al. 35 | Iran | 2013-2015 | Population-based | 547 | 1057 | - | 1.23 | 0.61-2.46 | 0.560 |
| Use of OTC antibiotics | ||||||||||
| Weekly | Eftekharian et al. 27 | Iran | 2013 | Population-based | 250 | 250 | 1.98 | - | 0.44-3.96 | |
| 1-2 times per month | Eftekharian et al. 27 | Iran | 2013 | Population-based | 250 | 250 | 1.55 | - | 0.62-3.84 | |
| Antibacterial soap usage | ||||||||||
| 1-2 per week | Eftekharian et al. 27 | Iran | 2013 | Population-based | 250 | 250 | 0.18 | - | 0.08-0.40 | - |
| 1-2 per month | Eftekharian et al. 27 | Iran | 2013 | Population-based | 250 | 250 | 0.43 | - | 0.22-0.82 | - |
| History of OCP usage | Rejali et al. 26 | Iran | 2014 | Hospital-based## (single center) |
200 | 200 | - | 0.49 | 0.31-0.77 | 0.002 |
| Duration of OCP usage | Rejali et al. 26 | Iran | 2014 | Hospital-based## (single center) |
200 | 200 | - | 0.88 | 0.80-0.96 | 0.008 |
| OCP starting age | Rejali et al. 26 | Iran | 2014 | Hospital-based## (single center) |
200 | 200 | - | 0.99 | 0.92-1.05 | 0.800 |
Significant results are bolded;
OTC: Over the counter; OR: Odds ratio; AOR: Adjusted odds ratio; CI: Confidence interval; OCP: Oral contraceptive pill
Taking 5 cigarette per day;
Taking 3-5 cigarette per day;
The study evaluated smoking as a risk factor for developing secondary progressive multiple sclerosis (SPMS);
Ever being exposed to passive smoking;
Adjusted mostly for age and sex;
Cases and controls were recruited from the same hospital;
Controls were recruited from Kuwaiti community living in Kuwait